chr2-168973818-A-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003742.4(ABCB11):ā€‹c.1331T>Cā€‹(p.Val444Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.591 in 1,610,750 control chromosomes in the GnomAD database, including 282,763 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V444D) has been classified as Likely benign.

Frequency

Genomes: š‘“ 0.57 ( 25038 hom., cov: 30)
Exomes š‘“: 0.59 ( 257725 hom. )

Consequence

ABCB11
NM_003742.4 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 2.39
Variant links:
Genes affected
ABCB11 (HGNC:42): (ATP binding cassette subfamily B member 11) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is the major canalicular bile salt export pump in man. Mutations in this gene cause a form of progressive familial intrahepatic cholestases which are a group of inherited disorders with severe cholestatic liver disease from early infancy. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.0099598E-5).
BP6
Variant 2-168973818-A-G is Benign according to our data. Variant chr2-168973818-A-G is described in ClinVar as [Benign]. Clinvar id is 194214.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-168973818-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.697 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ABCB11NM_003742.4 linkuse as main transcriptc.1331T>C p.Val444Ala missense_variant 13/28 ENST00000650372.1 NP_003733.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ABCB11ENST00000650372.1 linkuse as main transcriptc.1331T>C p.Val444Ala missense_variant 13/28 NM_003742.4 ENSP00000497931 P1

Frequencies

GnomAD3 genomes
AF:
0.572
AC:
86689
AN:
151500
Hom.:
25023
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.567
Gnomad AMI
AF:
0.660
Gnomad AMR
AF:
0.463
Gnomad ASJ
AF:
0.575
Gnomad EAS
AF:
0.717
Gnomad SAS
AF:
0.567
Gnomad FIN
AF:
0.511
Gnomad MID
AF:
0.554
Gnomad NFE
AF:
0.597
Gnomad OTH
AF:
0.580
GnomAD3 exomes
AF:
0.569
AC:
141494
AN:
248542
Hom.:
41134
AF XY:
0.574
AC XY:
77402
AN XY:
134806
show subpopulations
Gnomad AFR exome
AF:
0.571
Gnomad AMR exome
AF:
0.423
Gnomad ASJ exome
AF:
0.558
Gnomad EAS exome
AF:
0.728
Gnomad SAS exome
AF:
0.576
Gnomad FIN exome
AF:
0.515
Gnomad NFE exome
AF:
0.599
Gnomad OTH exome
AF:
0.564
GnomAD4 exome
AF:
0.593
AC:
864780
AN:
1459132
Hom.:
257725
Cov.:
40
AF XY:
0.592
AC XY:
429695
AN XY:
725906
show subpopulations
Gnomad4 AFR exome
AF:
0.578
Gnomad4 AMR exome
AF:
0.424
Gnomad4 ASJ exome
AF:
0.563
Gnomad4 EAS exome
AF:
0.728
Gnomad4 SAS exome
AF:
0.569
Gnomad4 FIN exome
AF:
0.512
Gnomad4 NFE exome
AF:
0.602
Gnomad4 OTH exome
AF:
0.587
GnomAD4 genome
AF:
0.572
AC:
86740
AN:
151618
Hom.:
25038
Cov.:
30
AF XY:
0.566
AC XY:
41919
AN XY:
74026
show subpopulations
Gnomad4 AFR
AF:
0.567
Gnomad4 AMR
AF:
0.463
Gnomad4 ASJ
AF:
0.575
Gnomad4 EAS
AF:
0.716
Gnomad4 SAS
AF:
0.568
Gnomad4 FIN
AF:
0.511
Gnomad4 NFE
AF:
0.597
Gnomad4 OTH
AF:
0.583
Alfa
AF:
0.598
Hom.:
53383
Bravo
AF:
0.571
TwinsUK
AF:
0.602
AC:
2231
ALSPAC
AF:
0.611
AC:
2354
ESP6500AA
AF:
0.586
AC:
2194
ESP6500EA
AF:
0.600
AC:
4941
ExAC
AF:
0.579
AC:
69942
Asia WGS
AF:
0.659
AC:
2292
AN:
3476
EpiCase
AF:
0.608
EpiControl
AF:
0.611

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingGeneDxJan 08, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Nov 14, 2014- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpDec 03, 2021- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Progressive familial intrahepatic cholestasis type 2 Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaMar 06, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -
Benign recurrent intrahepatic cholestasis type 2 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
18
DANN
Benign
0.97
DEOGEN2
Benign
0.27
T;T
Eigen
Benign
-0.43
Eigen_PC
Benign
-0.19
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.71
.;T
MetaRNN
Benign
0.000020
T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
0.14
N;N
MutationTaster
Benign
0.076
P
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
0.010
N;.
REVEL
Benign
0.26
Sift
Benign
0.25
T;.
Sift4G
Benign
0.59
T;.
Polyphen
0.0010
B;B
Vest4
0.055
MPC
0.17
ClinPred
0.013
T
GERP RS
4.6
Varity_R
0.10
gMVP
0.68

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2287622; hg19: chr2-169830328; COSMIC: COSV55585312; COSMIC: COSV55585312; API